NCT02718144View on ClinicalTrials.gov

Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Breast Neoplasms
Interventions
DRUG

Estetrol

Estetrol formulated in tablets, in escalating doses, will be investigated in patients with estrogen receptor positive (ER+) locally advanced or metastatic breast cancer.

Trial Locations (2)

Unknown

Katholisches Klinikum Mainz, Mainz

Universitatsmedizin Mainz, Mainz

Sponsors
All Listed Sponsors
lead

Pantarhei Oncology B.V.

OTHER

NCT02718144 - Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer | Biotech Hunter | Biotech Hunter